PetMeds- Huge Short Squeeze Potential?
The company has $93 million in cash with a market cap of $486 million. Cash on hand is about 20% of the market cap, with no debt and only liabilities for inventory.
225Research strives to find strong investment opportunities and aims to provide in-depth and insightful analysis of these opportunities for our readers.
The company has $93 million in cash with a market cap of $486 million. Cash on hand is about 20% of the market cap, with no debt and only liabilities for inventory.